Tocagen, Forte Biosciences In Merger
socalTECH
FEBRUARY 20, 2020
The newly merged company will operate under the name Forte Biosciences, and trade on the Nasdaq Capital Market as FBRX. The merged company will focus on Forte's late-stage clinical program for treating atopic dermatitis. READ MORE>>.
Let's personalize your content